| 000 | 01739 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517231659.0 | ||
| 264 | 0 | _c20191104 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a2284-0729 | ||
| 024 | 7 |
_a10.26355/eurrev_201808_15647 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHu, S | |
| 245 | 0 | 0 |
_aInteraction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®). _h[electronic resource] |
| 260 |
_bEuropean review for medical and pharmacological sciences _c08 2018 |
||
| 300 |
_a5042-5046 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnticoagulants _xchemistry |
| 650 | 0 | 4 |
_aAspirin _xchemistry |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aClopidogrel _xchemistry |
| 650 | 0 | 4 |
_aCurcumin _xchemistry |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoarthritis _xdrug therapy |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aThyroxine _xchemistry |
| 650 | 0 | 4 |
_aTiclopidine _xchemistry |
| 650 | 0 | 4 |
_aWarfarin _xchemistry |
| 700 | 1 | _aBelcaro, G | |
| 700 | 1 | _aDugall, M | |
| 700 | 1 | _aPeterzan, P | |
| 700 | 1 | _aHosoi, M | |
| 700 | 1 | _aLedda, A | |
| 700 | 1 | _aRiva, A | |
| 700 | 1 | _aGiacomelli, L | |
| 700 | 1 | _aTogni, S | |
| 700 | 1 | _aEggenhoffner, R | |
| 700 | 1 | _aCotellese, R | |
| 773 | 0 |
_tEuropean review for medical and pharmacological sciences _gvol. 22 _gno. 15 _gp. 5042-5046 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.26355/eurrev_201808_15647 _zAvailable from publisher's website |
| 999 |
_c28693313 _d28693313 |
||